Epigenetic analysis of KSHV latent and lytic genomes
- PMID: 20661424
- PMCID: PMC2908616
- DOI: 10.1371/journal.ppat.1001013
Epigenetic analysis of KSHV latent and lytic genomes
Abstract
Epigenetic modifications of the herpesviral genome play a key role in the transcriptional control of latent and lytic genes during a productive viral lifecycle. In this study, we describe for the first time a comprehensive genome-wide ChIP-on-Chip analysis of the chromatin associated with the Kaposi's sarcoma-associated herpesvirus (KSHV) genome during latency and lytic reactivation. Depending on the gene expression class, different combinations of activating [acetylated H3 (AcH3) and H3K4me3] and repressive [H3K9me3 and H3K27me3] histone modifications are associated with the viral latent genome, which changes upon reactivation in a manner that is correlated with their expression. Specifically, both the activating marks co-localize on the KSHV latent genome, as do the repressive marks. However, the activating and repressive histone modifications are mutually exclusive of each other on the bulk of the latent KSHV genome. The genomic region encoding the IE genes ORF50 and ORF48 possesses the features of a bivalent chromatin structure characterized by the concomitant presence of the activating H3K4me3 and the repressive H3K27me3 marks during latency, which rapidly changes upon reactivation with increasing AcH3 and H3K4me3 marks and decreasing H3K27me3. Furthermore, EZH2, the H3K27me3 histone methyltransferase of the Polycomb group proteins (PcG), colocalizes with the H3K27me3 mark on the entire KSHV genome during latency, whereas RTA-mediated reactivation induces EZH2 dissociation from the genomic regions encoding IE and E genes concurrent with decreasing H3K27me3 level and increasing IE/E lytic gene expression. Moreover, either the inhibition of EZH2 expression by a small molecule inhibitor DZNep and RNAi knockdown, or the expression of H3K27me3-specific histone demethylases apparently induced the KSHV lytic gene expression cascade. These data indicate that histone modifications associated with the KSHV latent genome are involved in the regulation of latency and ultimately in the control of the temporal and sequential expression of the lytic gene cascade. In addition, the PcG proteins play a critical role in the control of KSHV latency by maintaining a reversible heterochromatin on the KSHV lytic genes. Thus, the regulation of the spatial and temporal association of the PcG proteins with the KSHV genome may be crucial for propagating the KSHV lifecycle.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection.PLoS Pathog. 2013;9(12):e1003813. doi: 10.1371/journal.ppat.1003813. Epub 2013 Dec 19. PLoS Pathog. 2013. PMID: 24367262 Free PMC article.
-
Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.J Virol. 2014 Jun;88(11):6355-67. doi: 10.1128/JVI.00219-14. Epub 2014 Mar 26. J Virol. 2014. PMID: 24672028 Free PMC article.
-
ZIC2 Is Essential for Maintenance of Latency and Is a Target of an Immediate Early Protein during Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.J Virol. 2017 Oct 13;91(21):e00980-17. doi: 10.1128/JVI.00980-17. Print 2017 Nov 1. J Virol. 2017. PMID: 28835494 Free PMC article.
-
Molecular biology of KSHV lytic reactivation.Viruses. 2015 Jan 14;7(1):116-53. doi: 10.3390/v7010116. Viruses. 2015. PMID: 25594835 Free PMC article. Review.
-
Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication.Semin Cancer Biol. 2009 Jun;19(3):153-7. doi: 10.1016/j.semcancer.2009.02.010. Epub 2009 Feb 21. Semin Cancer Biol. 2009. PMID: 19429478 Free PMC article. Review.
Cited by
-
Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen.J Biol Chem. 2012 Feb 17;287(8):5806-18. doi: 10.1074/jbc.M111.289496. Epub 2011 Dec 16. J Biol Chem. 2012. PMID: 22179613 Free PMC article.
-
Association of Kaposi's Sarcoma-Associated Herpesvirus ORF31 with ORF34 and ORF24 Is Critical for Late Gene Expression.J Virol. 2015 Jun;89(11):6148-54. doi: 10.1128/JVI.00272-15. Epub 2015 Mar 25. J Virol. 2015. PMID: 25810551 Free PMC article.
-
Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency.PLoS Pathog. 2018 Sep 13;14(9):e1007267. doi: 10.1371/journal.ppat.1007267. eCollection 2018 Sep. PLoS Pathog. 2018. PMID: 30212584 Free PMC article.
-
Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells.mBio. 2022 Feb 22;13(1):e0347321. doi: 10.1128/mbio.03473-21. Epub 2022 Jan 4. mBio. 2022. PMID: 35089062 Free PMC article.
-
RNA decay during gammaherpesvirus infection reduces RNA polymerase II occupancy of host promoters but spares viral promoters.PLoS Pathog. 2020 Feb 7;16(2):e1008269. doi: 10.1371/journal.ppat.1008269. eCollection 2020 Feb. PLoS Pathog. 2020. PMID: 32032393 Free PMC article.
References
-
- Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693–705. - PubMed
-
- MacDonald VE, Howe LJ. Histone acetylation: where to go and how to get there. Epigenetics. 2009;4:139–143. - PubMed
-
- Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. High-resolution profiling of histone methylations in the human genome. Cell. 2007;129:823–837. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 DE019085/DE/NIDCR NIH HHS/United States
- AI073099/AI/NIAID NIH HHS/United States
- R01 CA082057/CA/NCI NIH HHS/United States
- R01 CA115284/CA/NCI NIH HHS/United States
- R01 AI073099/AI/NIAID NIH HHS/United States
- RC2 CA148616/CA/NCI NIH HHS/United States
- R01 CA082057-13/CA/NCI NIH HHS/United States
- R01 CA031363/CA/NCI NIH HHS/United States
- CA148616/CA/NCI NIH HHS/United States
- DE019085/DE/NIDCR NIH HHS/United States
- CA31363/CA/NCI NIH HHS/United States
- CA082057/CA/NCI NIH HHS/United States
- CA115284/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
